07:00 , May 2, 2016 |  BC Week In Review  |  Financial News

AtriCure completes debt financing

AtriCure Inc. (NASDAQ:ATRC), West Chester, Ohio   Business: Cardiovascular   Date completed: 2016-04-25   Type: Debt financing   Raised: $25 million   Investor: Silicon Valley Bank   Note: The five-year loan bears interest at the...
08:00 , Jan 26, 2015 |  BC Week In Review  |  Company News

AtriCure management update

AtriCure Inc. (NASDAQ:ATRC), West Chester, Ohio   Business: Cardiovascular   Promoted: Andy Wade to SVP from VP, while remaining CFO   Transitioned: Douglas Seith to COO from SVP of S&M  ...
08:00 , Jan 27, 2014 |  BC Week In Review  |  Financial News

AtriCure financial update

AtriCure filed a shelf registration covering the sale of up to $150 million of its securities. The company, which closed Friday at $21.04, has 23.2 million shares outstanding. AtriCure Inc. (NASDAQ:ATRC), West Chester, Ohio  ...
08:00 , Jan 2, 2012 |  BC Week In Review  |  Clinical News

Synergy Ablation System regulatory update

FDA approved a PMA for AtriCure's Synergy Ablation System to treat atrial fibrillation (AF) during open-heart concomitant coronary artery bypass grafting and/or valve replacement or repair procedures. AtriCure is required to conduct a post-approval study...
08:00 , Nov 7, 2011 |  BC Week In Review  |  Clinical News

Synergy Ablation System regulatory update

FDA's Circulatory System Devices Panel voted 5-3, with 1 abstention, that the benefits of AtriCure's Synergy Ablation System outweigh the risks to treat atrial fibrillation (AF) during open-heart concomitant surgical procedures. The panel voted 9-0...